ARIA might be the next HGSI
For ARIA, the last three days have been exciting. While shares closed below the open, which is typically bearish, today's move is more likely a head fake.
An interim look at phase 3 data for ridaforolimus (rida) is due any day now. If the phase 3 data are good, ARIA should advance much higher from today's close of $2.80.
From my view, rida is likely to be a winner. Check out Carolyn Boone's story and the results she achieved with rida - very compelling. Carolyn's story is summarized on pages 4 thru 7 of this recent ARIA presentation.
WEBCAST JULY 30 4:15 PM
ARIA will host a webcast on Thursday, July 30, 2009 at 4:15 PM ET. Interested investors ought to make it a point to check it out. After the close on Thursday, access the webcast here.
Universal Care should fail to gain enough momentum to pass in the House of Representatives.
For this reason, the healthcare sector will continue to be in demand. Buy Biotech, namely Small-Cap, Late-Stage Drug Makers. Need ideas? See this article on Lucky 13 Buys.
And keep your eye on ARIA.
Disclosure: Long ARIA and SPPI.